IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $380,000 | -77.8% | 30,000 | -43.8% | 0.08% | -92.9% |
| Q1 2016 | $1,709,000 | -25.1% | 53,373 | 0.0% | 1.12% | +31.1% |
| Q4 2015 | $2,282,000 | +2.3% | 53,373 | -15.8% | 0.85% | +5.3% |
| Q3 2015 | $2,231,000 | -16.0% | 63,373 | +9.6% | 0.81% | +0.1% |
| Q2 2015 | $2,655,000 | +115.9% | 57,823 | +120.3% | 0.81% | +51.7% |
| Q1 2015 | $1,230,000 | +49.1% | 26,243 | +0.8% | 0.53% | -14.1% |
| Q4 2014 | $825,000 | – | 26,034 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |